Speech-Language Pathologists in Havelock, NC Accepting Medicare
6 Speech-Language Pathologists found. Showing 1 - 6
 Jillian Daigneault Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 Stonebridge Sq, Havelock, NC 28532 Phone: 252-571-2078 Fax: 252-649-1796 |
Natasia Sara Daloisio, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 Stonebridge Sq, Havelock, NC 28532 Phone: 252-571-2078 |
Kerry Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Mccotter Blvd, Havelock, NC 28532 Phone: 252-444-4631 |
Mrs. Lauren Honsinger Harrell, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Webb Blvd, Havelock, NC 28532 Phone: 252-447-3892 |
Jessie Cronk, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Pine Dale Rd, Havelock, NC 28532 Phone: 828-280-5174 |
Laurie Wilburn, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Apple Dr, Havelock, NC 28532 Phone: 518-669-7087 |
News Archive
High levels of physical activity reduce chronic disease risk in older adults
New research has shown that older adults who exercise above current recommended levels have a reduced risk of developing chronic disease compared with those who do not exercise.
New multicenter trial achieves 71% survival in AML children
More individualized therapy and better supportive care helped push the survival for children with acute myeloid leukemia (AML) to 71 percent three years after diagnosis, according to new research led by St. Jude Children's Research Hospital investigators and reported in the medical journal The Lancet Oncology. The survival rate of 71 percent is 20 percent better than previously reported U.S. rates and is similar to the success achieved in a 2009 Japanese study, said Jeffrey Rubnitz, M.D., Ph.D., a member of the St. Jude Oncology department.
Losing weight and keeping it off could help stabilize or improve cardiometabolic risk factors
People who lose weight and keep it off can stabilize or even improve their cardiometabolic risk factors compared to people who regain weight, finds a new study led by researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts.
World's largest public-private partnership focuses on tackling antibiotic resistance
The U.S. Department of Health and Human Services, the Wellcome Trust of London, the AMR Centre of Alderley Park, Cheshire in the United Kingdom and Boston University School of Law today announced the establishment of one of the world's largest public-private partnerships focused on tackling antibiotic resistance, an emerging modern threat to public health worldwide.
Dapagliflozin in addition to insulin improves glycemic control in type 2 diabetics
Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were treated with insulin (with or without oral anti-diabetes medications (OADs)), compared to placebo plus insulin (with or without OADs).
› Verified 5 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists